ZIVO Bioscience, Inc.

ZIVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $507.0K $16.6K $1.4K $493.1K $47.1K $225.7K $15.6K
Accounts Receivable — — — — — — —
Inventory — — — — — $0 $10.6K
Total Current Assets $520.4K $28.9K $33.1K $688.5K $90.8K $249.8K $37.0K
Property, Plant & Equipment $18.8K $43.8K $68.8K $1.4M $13.2K $83.5K $170.3K
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — $0 $6.2K $7.2K $8.2K
Total Assets $737.3K $72.7K $101.9K $2.2M $234.0K $463.5K $339.9K
Liabilities
Accounts Payable $666.4K $1.1M $1.2M $483.2K $938.6K $660.6K $455.6K
Total Current Liabilities $11.2M $5.0M $6.2M $10.9M $3.4M $1.8M $780.5K
Long-Term Debt — — — — — — —
Total Liabilities $14.4M $9.6M $6.5M $11.8M $4.2M $2.5M $1.3M
Stockholders' Equity
Retained Earnings $-53.8M $-47.7M $-41.9M $-42.6M $-32.5M $-29.3M $-26.5M
Total Stockholders' Equity $-13.6M $-9.5M $-6.4M $-9.6M $-4.0M $-2.0M $-951.7K
← Newer Page 2 of 2 Older →